These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3435146)

  • 1. Simplified purification method for Clostridium botulinum type E toxin.
    Giménez JA; Sugiyama H
    Appl Environ Microbiol; 1987 Dec; 53(12):2827-30. PubMed ID: 3435146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of a homogeneous Cl. botulinum type B neurotoxin].
    Saprykina TP; Kliucheva VV; Blagoveshchenskiĭ VA; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):86-91. PubMed ID: 6778041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
    Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
    Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Production of monospecific type A botulinum toxin and antiserum using a column chromatographic method].
    Marchev N; Marcheva D
    Vet Med Nauki; 1982; 19(1):57-63. PubMed ID: 6810534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid method for purification of Clostridium botulinuh type C neurotoxin by High Performance Liquid Chromatography (HPLC ).
    Matsuda M; Ozutsumi K; Pei-Ying D; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-271. PubMed ID: 29464575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.
    Sugiyama H; Moberg LJ; Messer SL
    Appl Environ Microbiol; 1977 Apr; 33(4):963-6. PubMed ID: 405926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.
    Miyata K; Sagane Y; Inui K; Miyashita S; Suzuki T; Oguma K; Ohyama T; Niwa K; Watanabe T
    Protein J; 2012 Jun; 31(5):387-92. PubMed ID: 22565346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.